Showing 2261-2270 of 5616 results for "".
Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
https://reachmd.com/programs/cme/treatment-of-oab-and-the-managed-care-professional-balancing-the-double-edged-sword/15362/Are you prepared to actively engage with your patients about their overactive bladder?Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
https://reachmd.com/programs/cme/pulmonary-hypertension-getting-the-right-diagnosis-and-knowing-when-to-refer/36094/Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to ReferCost Considerations for Colorectal Cancer Screening: Examining the Data
https://reachmd.com/programs/clinicians-roundtable/cost-considerations-for-colorectal-cancer-screening-examining-the-data/33054/A recent study explored three emerging colorectal cancer (CRC) screening tests—mt-sRNA, multitarget stool DNA 2.0, and cell-free DNA—in terms of their cost-effectiveness, comparing them to traditional methods such as colonoscopy and fecal immunochemical testing. Learn which methods offer the best baHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
https://reachmd.com/programs/dermconsult/how-systemic-psoriasis-therapies-influence-the-risk-of-new-or-recurrent-maces/32810/Truths and Myths About Facial Danger Zones When Injecting Soft Tissue Fillers
https://reachmd.com/programs/modern-aesthetics/truths-and-myths-about-facial-danger-zones-when-injecting-soft-tissue-fillers/39264/Despite the current dip in demand for aesthetic treatments with soft tissue fillers, minimally invasive procedures remain popular and are widely accepted as alternatives to facial surgery.Enhancing IgAN Care: The Importance of a Proactive Approach
https://reachmd.com/programs/clinicians-roundtable/enhancing-igan-care-the-importance-of-a-proactive-approach/37213/Although IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world, it’s easy to miss and can lead to irreversible kidney damage, underscoring the importance of proactively identifying, monitoring, and treating patients. That’s why Dr. Gates Colbert speaks with Dr. Suneel UdaAdvancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
https://reachmd.com/programs/project-oncology/advancing-noninvasive-crc-screening-exploring-an-aptamer-based-assay/36407/With one in three eligible Americans still unscreened for colorectal cancer (CRC), there’s an urgent need for noninvasive and affordable alternatives to colonoscopy. A 2025 study published in ACS Sensors introduces a novel aptamer-based colorimetric assay that targets Parvimonas micra—a gut microbeHonoring Age with Science and Strategy
https://reachmd.com/ma-issues-index/july-august-2025/honoring-age-science-strategy/36655/Mature beauty is not a consolation prize. It is an architectural project that honors decades of expression and experience. Diagnose every layer, match modality to mechanism, and remind your patient that elegance at 80 is never accidental. It is engineered.Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
https://reachmd.com/programs/neurofrontiers/gut-microbiota-and-pediatric-ms-new-insights-into-potential-disease-drivers/26487/A new study investigating the relationship between gut microbiota composition and pediatric-onset multiple sclerosis (MS) offers evidence that a depletion of short-chain fatty acid (SCFA) producers may play a role in the disease's pathogenesis. Discover how these findings have the potential to infor